Federal contractor · public award history
BIOGEN U.S. CORPORATION
Parent: BIOGEN U.S. CORPORATION X7PVCG2SP9R1
- Awards we know about
- 4
- Typical size
- $43,477
- Middle of their public awards
- Dollars on those awards
- $43,477
Most of their awards we can see fall roughly between $43,477 and $43,477.
SAM.gov registration
Public extract 2026-07-05
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Jun 2, 2027
- Activation date
- Jun 2, 2026
- Primary NAICS (SAM)
- 325412
Other NAICS on file
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Awarding agencies
- Department of Veterans Affairs (4)
Industries & product codes
Award history
- Department of Veterans Affairs—
65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
- Department of Veterans Affairs—
BPA FOR SPINRAZA
- Department of Veterans Affairs—
NEW AWARD FOR RANIBIZUMAB (BYOOVIZ) VIALS WITH BIOGEN U.S. CORPORATION. PERIOD OF PERFORMANCE IS 12/23/23 TO 12/22/24 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs$43,477
QALSODY BULK
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.